Neuromod and Treble Health Partner to Expand Lenire Access
The partnership makes the bimodal neuromodulation device for tinnitus available through clinics in Philadelphia and Charlotte.
The partnership makes the bimodal neuromodulation device for tinnitus available through clinics in Philadelphia and Charlotte.
Neuromod Devices has achieved both Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification, enabling expanded global availability of its Lenire tinnitus treatment device in Europe, Canada, Australia, and beyond.
PNQ Health received FDA clearance for its Class II SaMD digital health platform, offering a telemedicine-based approach to treat tinnitus.
Oto and Lindus Health announced the launch of a fully remote, digital trial to increase patient access to life-changing tinnitus therapy.
Read MoreWidex published the preliminary results of a study which validates the use of fractal sound stimulation in treating tinnitus.
Read MoreIn this case study, a clinical audiologist used Neuromod’s Lenire to treat a problem with tinnitus in a patient with acoustic neuroma.
Read MoreWidex Zen Therapy provides counseling to help patients understand and accept the condition, amplification for the majority of people with bothersome tinnitus who also have hearing loss, sound stimulation in the form of the Zen fractal tones, and relaxation techniques that can help break a vicious circle of tinnitus exacerbating stress and vice versa.
Read MoreEven though there is no cure for tinnitus today, good approaches that significantly reduce the burden of affected individuals are available. Therefore, it is hoped that the message to sufferers that they have to “live with their tinnitus” will become less and less pronounced.
Read MoreAfter 20 years searching for a cure for tinnitus, researchers at the University of Auckland are excited by ‘encouraging results’ from a clinical trial of a mobile-phone-based therapy, according to an article on the University’s website.
Read MoreNeuromod Devices Ltd has reached an agreement with Specialklinikken Borgå ApS, a Danish provider of private care for tinnitus, to make its Lenire device available in Denmark.
Read MoreAn international team, including a University of Minnesota professor, has published a second large clinical trial for a novel neuromodulation device, Lenire, that could reduce symptoms for millions worldwide with tinnitus, commonly described as “ringing in the ears.” Researchers published the results of the Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2 (TENT-A2) clinical trial in “Nature – Scientific Reports.” An article detailing the research appears on the University of Minnesota website.
Read Moreresults of the company’s TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in “Nature – Scientific Reports” in a paper titled “Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial.”
Read MoreTinnitus has plagued mankind for millennia. Yet, too often when those who have tinnitus seek professional help, they are told they will have to learn to live with it.
Read MoreAccording to the British Tinnitus Association, around 30% of people experience tinnitus, with 13% (1 in 8) having persistent tinnitus. For such a common condition, many people do not understand the impact it can have.
Read MoreIt is reported that 10-15% of the global adult population suffers from tinnitus 1-4, the chronic phantom auditory percept that has been attributed to abnormal firing patterns in the brain.4 According to the American Tinnitus Association (ATA), 45 million Americans reported experiencing tinnitus in the US Centers for Disease Control (CDC) National Health and Nutritional Examination Survey.
Read MoreAustralian author and academic David Tuffley challenges bold claims that a neuroprosthetic device developed by Elon Musk’s Neuralink start-up company could “cure tinnitus” within five years, in an article on “The Conversation” website.
Read MoreEdited by Aniruddha Deshpande and James Hall, III, the new textbook provides up-to-date and evidence-based information on tinnitus prevention, assessment, and management.
Read MoreUS-based audiology telehealth company Treble Health and Oto, the UK-based digital health startup for tinnitus support, have announced a collaboration to allow Oto app users to access Treble Health’s team of audiologists for telehealth consultations.
Read More